Newsroom | 58912 results

OKLAHOMA CITY--(BUSINESS WIRE)--Chloeta, a premier provider of engineering, scientific and technical solutions to support military, energy, homeland security, emergency preparedness and critical infrastructure requirements, is pleased to announce its achievement of ISO 9001 certification for its Quality Management System (QMS). This milestone reinforces Chloeta’s position as an industry leader in regulatory excellence. This certification reflects Chloeta’s ongoing commitment to maintaining the...

MANHASSET, N.Y.--(BUSINESS WIRE)--Researchers at Northwell Health’s Feinstein Institutes for Medical Research found that obinutuzumab, a therapeutic antibody that depletes B cells and is approved for the treatment of B cell malignancies, benefitted patients with lupus nephritis, a severe complication of lupus that compromises kidney function. The study, which was led by Richard A. Furie, MD, professor in the Feinstein Institutes’ Institute of Molecular Medicine and The Marilyn and Barry Rubenst...

RUTHERFORD, Calif.--(BUSINESS WIRE)--One Mind is now actively accepting applications for the 2025 One Mind Rising Star Awards program. Since its founding, One Mind has supported the curiosity and drive of the most promising early career scientists, enabling stunning breakthroughs and launching their careers as leaders. In 2005, One Mind formalized this strategy, launching the Rising Star Awards program with the fundamental belief that investing in world-class early-career investigators pursuing...

OXFORD, England--(BUSINESS WIRE)--A new paper, released this week on bioRxiv, introduces hifiasm-ONT, a breakthrough genome assembly algorithm that enables partially phased, near telomere-to-telomere (T2T) assemblies1, using Oxford Nanopore Simplex reads and standard sample prep. Developed by Haoyu Cheng, Han Qu, Heng Li, and Peter Park, with support from Oxford Nanopore’s machine learning and applications teams, this major algorithmic innovation unlocks the length advantage of Oxford Nanopore’...

ABU DHABI, Emirati Arabi Uniti--(BUSINESS WIRE)--Abu Dhabi ha lanciato l'innovativo cluster dedicato al settore delle scienze della vita, rafforzando la sua posizione di hub globale per la biotecnologia, la tecnologia medica e la sanità digitale. Sviluppato dal Dipartimento per lo Sviluppo Economico di Abu Dhabi, dall'Ufficio per gli Investimenti di Abu Dhabi (ADIO) e dal Dipartimento della Salute di Abu Dhabi, il cluster HELM (Health, Endurance, Longevity, and Medicine) è stato progettato per...

ABU DHABI, Verenigde Arabische Emiraten--(BUSINESS WIRE)--Abu Dhabi heeft het baanbrekende life sciences-cluster gelanceerd, waardoor de positie van het land als een wereldwijde hub voor biotechnologie, MedTech en digitale gezondheid wordt versterkt. Het Health, Endurance, Longevity and Medicine (HELM)-cluster is ontwikkeld door het Abu Dhabi Department of Economic Development, Abu Dhabi Investment Office (ADIO) en het Department of Health – Abu Dhabi, en is ontworpen om innovatie in de gezondh...

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company specializing in the development of novel therapies to restore, treat and prevent hearing loss disorders, today announced that the Company’s shareholders are invited to participate in the Combined General Meeting, to be held on Wednesday, May 12, 2025, at 2 pm CET in the premises of the hotel Square Louvois, located at 12, rue de Louvois, 75002, Paris, France....

東京--(BUSINESS WIRE)--(美國商業資訊)-- Rigaku Holdings Corporation旗下子公司Rigaku Corporation（總部：東京昭島市；執行長：Jun Kawakami；以下簡稱「Rigaku」），與SPERA PHARMA, Inc.（總部：大阪市；董事長兼代表董事：Keitaro Iwaki；以下簡稱「SPERA PHARMA」）宣佈達成戰略合作，旨在通過整合雙方尖端技術與深厚專業知識，加速並革新藥物研發進程。 SPERA PHARMA將採用Rigaku提供的電子衍射集成平台XtaLAB Synergy-ED開展合約分析服務，為客戶的藥物研發提供強力支援。 XtaLAB Synergy-ED搭載的3D ED/MicroED1可用於物質結構分析，包括顯微晶體和微量結晶粉末。這項尖端技術具有足夠高的解析度，可以確定原子級結構，從而詳細闡明有機化合物及類似物質的分子結構。 SPERA PHARMA目前是全球醫藥行業唯一一家提供XtaLAB Synergy-ED合約分析服務的企業。Rigaku將為SPERA PHARMA的合約分析業務提供全面...

BILTHOVEN, Holanda y BOSTON--(BUSINESS WIRE)--Avania líder mundial en asesoramiento tecnológico y desarrollo clínico, ha anunciado hoy el nombramiento de Jasmine Saba como vicepresidente ejecutiva de Relaciones estratégicas y de Josh Blacker en el cargo de vicepresidente ejecutivo de Desarrollo del negocio global. Nombran a Saba vicepresidente ejecutiva de Relaciones estratégicas Saba asumirá este nuevo cargo para promover el crecimiento de Avania y para eso se encargará de identificar, estable...

PRINCETON, N.J.--(BUSINESS WIRE)--U.S. Food and Drug Administration Updates CAMZYOS® (mavacamten) Label to Reduce Echocardiography Monitoring Requirements and Contraindications...